These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

748 related articles for article (PubMed ID: 34517079)

  • 1. Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: A registry-based study.
    McMahon DE; Kovarik CL; Damsky W; Rosenbach M; Lipoff JB; Tyagi A; Chamberlin G; Fathy R; Nazarian RM; Desai SR; Lim HW; Thiers BH; Hruza GJ; French LE; Blumenthal K; Fox LP; Freeman EE
    J Am Acad Dermatol; 2022 Jan; 86(1):113-121. PubMed ID: 34517079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases.
    McMahon DE; Amerson E; Rosenbach M; Lipoff JB; Moustafa D; Tyagi A; Desai SR; French LE; Lim HW; Thiers BH; Hruza GJ; Blumenthal KG; Fox LP; Freeman EE
    J Am Acad Dermatol; 2021 Jul; 85(1):46-55. PubMed ID: 33838206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review on mucocutaneous presentations after COVID-19 vaccination and expert recommendations about vaccination of important immune-mediated dermatologic disorders.
    Seirafianpour F; Pourriyahi H; Gholizadeh Mesgarha M; Pour Mohammad A; Shaka Z; Goodarzi A
    Dermatol Ther; 2022 Jun; 35(6):e15461. PubMed ID: 35316551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dermatopathology of COVID-19 infection and vaccination.
    Fernández-Figueras MT
    Pathologie (Heidelb); 2022 Aug; 43(Suppl 1):114-118. PubMed ID: 36197514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and histopathological spectrum of delayed adverse cutaneous reactions following COVID-19 vaccination.
    Larson V; Seidenberg R; Caplan A; Brinster NK; Meehan SA; Kim RH
    J Cutan Pathol; 2022 Jan; 49(1):34-41. PubMed ID: 34292611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous Complications of mRNA and AZD1222 COVID-19 Vaccines: A Worldwide Review.
    Kroumpouzos G; Paroikaki ME; Yumeen S; Bhargava S; Mylonakis E
    Microorganisms; 2022 Mar; 10(3):. PubMed ID: 35336199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous manifestations of COVID-19 and COVID-19 vaccination.
    Nakashima C; Kato M; Otsuka A
    J Dermatol; 2023 Mar; 50(3):280-289. PubMed ID: 36636825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral erythema multiforme after Pfizer-BioNTech COVID-19 vaccination: a report of four cases.
    Petruzzi M; Galleggiante S; Messina S; Della Vella F
    BMC Oral Health; 2022 Mar; 22(1):90. PubMed ID: 35331228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases.
    Català A; Muñoz-Santos C; Galván-Casas C; Roncero Riesco M; Revilla Nebreda D; Solá-Truyols A; Giavedoni P; Llamas-Velasco M; González-Cruz C; Cubiró X; Ruíz-Villaverde R; Gómez-Armayones S; Gil Mateo MP; Pesqué D; Marcantonio O; Fernández-Nieto D; Romaní J; Iglesias Pena N; Carnero Gonzalez L; Tercedor-Sanchez J; Carretero G; Masat-Ticó T; Rodríguez-Jiménez P; Gimenez-Arnau AM; Utrera-Busquets M; Vargas Laguna E; Angulo Menéndez AG; San Juan Lasser E; Iglesias-Sancho M; Alonso Naranjo L; Hiltun I; Cutillas Marco E; Polimon Olabarrieta I; Marinero Escobedo S; García-Navarro X; Calderón Gutiérrez MJ; Baeza-Hernández G; Bou Camps L; Toledo-Pastrana T; Guilabert A
    Br J Dermatol; 2022 Jan; 186(1):142-152. PubMed ID: 34254291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant Severe Psoriasis and Bullous Pemphigoid Induced by COVID-19.
    Martora F; Battista T; Fabbrocini G; Megna M
    Trop Med Infect Dis; 2023 Feb; 8(2):. PubMed ID: 36828523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous reactions after COVID-19 vaccination in Turkey: A multicenter study.
    Cebeci Kahraman F; Savaş Erdoğan S; Aktaş ND; Albayrak H; Türkmen D; Borlu M; Arıca DA; Demirbaş A; Akbayrak A; Polat Ekinci A; Gökçek GE; Çelik HA; Taşolar MK; An İ; Temiz SA; Hazinedar E; Ayhan E; Hızlı P; Solak EÖ; Kılıç A; Yılmaz E
    J Cosmet Dermatol; 2022 Sep; 21(9):3692-3703. PubMed ID: 35780311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed Localized Hypersensitivity Reactions to the Moderna COVID-19 Vaccine: A Case Series.
    Johnston MS; Galan A; Watsky KL; Little AJ
    JAMA Dermatol; 2021 Jun; 157(6):716-720. PubMed ID: 33978670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of coronavirus disease 2019 vaccine-induced cutaneous complications: A comprehensive literature review.
    Bin Rubaian NF; Aljalfan AA; Almuhaidib SR
    J Family Community Med; 2023; 30(3):161-170. PubMed ID: 37675215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bullous pemphigoid after second dose of mRNA- (Pfizer-BioNTech) Covid-19 vaccine: A case report.
    Alshammari F; Abuzied Y; Korairi A; Alajlan M; Alzomia M; AlSheef M
    Ann Med Surg (Lond); 2022 Mar; 75():103420. PubMed ID: 35251600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of COVID-19 Vaccination on Inflammatory Skin Disorders and Other Cutaneous Diseases: A Review of the Published Literature.
    Martora F; Battista T; Ruggiero A; Scalvenzi M; Villani A; Megna M; Potestio L
    Viruses; 2023 Jun; 15(7):. PubMed ID: 37515110
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinicopathological characteristics of cutaneous complications following COVID-19 vaccination: A case series.
    Diab R; Rakhshan A; Salarinejad S; Pourani MR; Ansar P; Abdollahimajd F
    J Cosmet Dermatol; 2024 Mar; 23(3):725-730. PubMed ID: 37899662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Unusual Presentation of Erythema Multiforme Following the Administration of Pfizer-BioNTech COVID-19 mRNA Vaccine in a Pediatric Patient.
    Alghamdi Y; Abdulghani F; Huwait HF; Abdulghani M; Samarkandy SJ
    Cureus; 2024 Apr; 16(4):e58450. PubMed ID: 38765345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical observation and analysis of skin reactions caused by COVID-19 vaccination.
    Li Y; Fan L; Mao Q; Luan X; Wang Z; Zeng N; Cheng Y; Li Y; Xia Q; Lu Z; Lu Q; Min W; Luo D
    Dermatol Ther; 2022 Oct; 35(10):e15746. PubMed ID: 36190010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.
    Rosenblum HG; Hadler SC; Moulia D; Shimabukuro TT; Su JR; Tepper NK; Ess KC; Woo EJ; Mba-Jonas A; Alimchandani M; Nair N; Klein NP; Hanson KE; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Mbaeyi SA; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(32):1094-1099. PubMed ID: 34383735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukocytoclastic vasculitis as a cutaneous manifestation of ChAdOx1 nCoV-19 corona virus vaccine (recombinant).
    Sandhu S; Bhatnagar A; Kumar H; Dixit PK; Paliwal G; Suhag DK; Patil C; Mitra D
    Dermatol Ther; 2021 Nov; 34(6):e15141. PubMed ID: 34546608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.